Hidden Viruses in COVID: What It Means for You and Recovery

Credibility

Interest

Share:2 min read

Key Takeaway

Many people with COVID-19, even those not known to have weak immune systems, can have dormant viruses wake up during acute illness and sometimes long after, which may affect recovery.

What They Found

Researchers studied blood samples from over 1,100 people hospitalized with COVID-19 and found that common dormant viruses (like Epstein-Barr virus and others in the herpes family) often start replicating again during the acute illness. Different viruses reactivated at different times—some early in the hospital stay, others later or even after people left the hospital. Viral reactivation was linked with more severe COVID-19, higher inflammation (the body's alarm system), and other signs that the immune system was working hard. Some viral activity persisted into recovery, and one family of small viruses (Anelloviridae) was associated with ongoing symptoms called long COVID. The team also identified patterns in immune signals and small molecules in the blood that go along with these viral reactivations, which could help predict or track them in the future.

Who Should Care and Why

People with MS and their caregivers should care because MS patients already manage immune-related symptoms and treatments that affect infections; a hidden virus reactivating could add fatigue, brain fog, or other symptoms that look like MS changes. Think of your body like a neighborhood: when one shop (immune control) gets overwhelmed by a storm (severe COVID), other troublemakers (dormant viruses) can start causing problems nearby. Care teams may want to watch for new or worsening symptoms after COVID-19 and consider whether viral reactivation could be a cause. This is especially relevant for patients on immune therapies, because even though reactivation can occur in people with normal immunity, treatments might change the pattern or risk. Knowing about these reactivations might help your doctor decide on tests, monitoring, or treatments to help recovery and reduce long COVID risk.

Important Considerations

The study shows links between viral reactivation and worse outcomes, but it does not prove the reactivated viruses cause the worse illness—both could be caused by the same stress on the body. Most participants were hospitalized, so results may not apply the same way to people with mild COVID who stayed home. Tests and treatments specifically targeting these reactivated viruses were not tested here, so any changes in care should be discussed with your healthcare team and based on further research.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Progression MS Diagnostics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Nature often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News